Breaking news on cervical cancer and HPV
Health Leaders Gather To Discuss WHO's Work In Africa published
Wed, 01 Sep 2010 04:00:00 PDT
Health leaders from 46 African WHO member states gathered in Malabo, Equatorial Guinea, on Monday for the 60th session of the Africa Committee of the WHO, Agencia AngolaPress reports...
STD Vaccine Viewed Positively According To Survey Of American Women published
Sat, 28 Aug 2010 00:00:00 PDT
Cost but not convenience plays a significant role in attitudes about vaccination for common human papillomaviruses for women over the age of 26, according to the authors of a recent article in the journal Sexual Health. Currently, the two vaccines for human papillomavirus (HPV), which is the primary cause of cervical cancer, are U.S...
Boston Globe Editorial Calls Attention To Unnecessary Pap Tests published
Fri, 27 Aug 2010 03:00:00 PDT
Even though an annual Pap test "is a long-standing, if much-dreaded, tradition" for many women, "a high proportion of these tests are unnecessary," according to a Boston Globe editorial. The editorial notes that "[g]uidelines recommend testing every two to three years for women at low risk of cervical cancer," such as women older than age 30 who have had multiple negative tests...
National Cancer Institute Funds Second Year Of Grant To Guided Therapeutics To Commercialize Non-invasive Cervical Cancer Detection Device published
Thu, 26 Aug 2010 05:00:00 PDT
Guided Therapeutics, Inc. (GT) (OTCBB: GTHP) announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009. The three-year grant provides additional resources to commercialize and bring to market the LightTouch™ non-invasive cervical cancer detection device and single-patient-use disposable...
GSK European Commission Amends Licence For Cervarix® published
Wed, 25 Aug 2010 05:00:00 PDT
GlaxoSmithKline (GSK) confirmed that the European Commission has granted Marketing Authorisation to amend the licence for its cervical cancer vaccine, Cervarix®. The approval from the European Commission is important as it recognises the extent of cervical cancer protection demonstrated by Cervarix®, which was not highlighted by the previous indication...
New ACOG Recommendations On HPV Vaccination Mirror Government Guidelines published
Wed, 25 Aug 2010 05:00:00 PDT
On Monday, the American College of Obstetricians and Gynecologists released recommendations that girls should be vaccinated against the human papillomavirus at ages 11 or 12, Reuters reports. The recommendations, published in the journal Obstetrics & Gynecology, back government guidelines on HPV vaccination...
Ob-Gyns Recommend HPV Vaccination For Young Girls published
Tue, 24 Aug 2010 03:00:00 PDT
Girls ages 11 to 12 should receive either of the two FDA-approved vaccines to prevent cervical cancer, ideally before they become sexually active, according to The American College of Obstetricians and Gynecologists...
The Society For Adolescent Health And Medicine (SAHM) Advocates For Ways To Improve Immunization Rates And Halt Disease Outbreaks published
Tue, 24 Aug 2010 00:00:00 PDT
In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents. The report issued by the National Immunization Survey (NIS) shows progress in increasing immunization rates among teens 13-17 years of age...
CDC Says Teen Vaccination Rates Up But Should Go Higher published
Mon, 23 Aug 2010 01:00:00 PDT
The Wall Street Journal writes about vaccination rates among teens: "The CDC says more teenagers got their recommended immunizations last year, but that there's room for improvement - for example, only 27% of teenage girls received the recommended three doses of human papilloma virus (HPV) vaccine. That's still an improvement of 9 percentage points from 2008...
Follow-Up After An Abnormal Pap Test Improved By Electronic Tracking System published
Mon, 23 Aug 2010 00:00:00 PDT
Researchers from Boston University School of Medicine (BUSM) report that physicians who use an automated, electronic medical record (EMR) tracking system to follow-up on patients with an abnormal Pap test could increase the number of women who achieved diagnostic resolution and have women achieve resolution in less time than using traditional methods...
NPR Examines Debate Over HPV Vaccination For Boys published
Mon, 23 Aug 2010 00:00:00 PDT
On Friday, NPR's "Morning Edition" examined arguments from both sides over whether boys should receive the human papillomavirus vaccine, which is FDA-approved to protect against strains of the sexually transmitted virus that can lead to cervical cancer in women and genital warts in both sexes (Wilson, "Morning Edition," NPR, 8/20)...
The Society For Adolescent Health And Medicine (SAHM) Advocates For Ways To Improve Immunization Rates And Halt Disease Outbreaks published
Sat, 21 Aug 2010 01:00:00 PDT
In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents. The report issued by the National Immunization Survey (NIS) shows progress in increasing immunization rates among teens 13-17 years of age...
Chemotherapy And Radiotherapy Work Together To Increase Cervical Cancer Survival Rates published
Sat, 21 Aug 2010 00:00:00 PDT
A combination of radiotherapy and drug treatment can be substantially more effective in treating cervical cancer that radiotherapy alone, says an audit published by The Royal College of Radiologists (RCR). The audit, appearing in the September 2010 edition of the RCR journal, Clinical Oncology, looked at over 1200 patients treated with radiotherapy in UK cancer centres in 2001 and 2002...
Significant Advance Announced In Treatment Of Cervical Cancer published
Sat, 21 Aug 2010 00:00:00 PDT
A medical researcher at the University of Leicester has made a significant advance in the treatment of cervical cancer. Dr Paul Symonds from the Department of Cancer Studies and Molecular Medicine has demonstrated that the use of a particular drug in collaboration with radiotherapy gives significantly better results than radiotherapy alone...
The Society For Adolescent Health And Medicine (SAHM) Advocates For Ways To Improve Immunization Rates And Halt Disease Outbreaks published
Fri, 20 Aug 2010 03:00:00 PDT
In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents. The report issued by the National Immunization Survey (NIS) shows progress in increasing immunization rates among teens 13-17 years of age...
Advaxis Completes Dosing Vanguard Group In Phase II Cervical Dysplasia (CIN) Study published
Fri, 20 Aug 2010 01:00:00 PDT
Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study...
Study Examines Ways To Reduce Growing Cancer Burden In Developing World published
Tue, 17 Aug 2010 04:00:00 PDT
"The growing burden of cancer in developing countries could be reduced without expensive drugs and equipment, scientists said on Monday, but it requires a global effort similar to the fight against HIV/AIDS," Reuters reports in an article that examines a study published in the Lancet by a group of American scientists who have created the Global Task Force on Expanded Access t...
Hmong-American Women Far Less Likely To Get Pap Test published
Sat, 07 Aug 2010 01:00:00 PDT
The Asian-American community of Hmong women in California carries a stunning burden of cervical cancer and resulting mortality four times as high as non-Hispanic white women in California do...
Dermatologist Discusses Advantages Of Vaccines That Prevent Human Papillomavirus And Herpes Zoster published
Fri, 06 Aug 2010 03:00:00 PDT
Vaccines have a long history of successfully preventing disease and, in effect, improving the lives of countless Americans. Now, two serious diseases human papillomavirus (HPV) and herpes zoster could become a thing of the past as people better understand the safety and efficacy of vaccines to prevent these serious viral infections in specific populations...
National Guidelines Not Closely Followed For HPV Vaccine published
Wed, 04 Aug 2010 01:00:00 PDT
The vast majority of pediatricians and family physicians nationally are offering the human papillomavirus (also called HPV) vaccine, though fewer physicians are strongly encouraging it for 11- to 12-year-old girls as recommended by national guidelines, according to a survey in the September issue of Pediatrics, the journal of the American Academy of Pediatrics...
Advaxis Phase I Survival Update published
Thu, 29 Jul 2010 06:00:00 PDT
Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy...
More Funding Needed For Breast, Cervical Cancer Detection Program, Advocates Say published
Thu, 29 Jul 2010 03:00:00 PDT
During an event to mark its 20th anniversary, advocates of the National Breast and Cervical Cancer Early Detection Program on Tuesday expressed frustration that the program has not been extended to more low-income women and urged Congress to increase funding, CQ HealthBeat reports...
Experts Concerned About Increase In HPV-Related Head And Neck Cancers published
Wed, 28 Jul 2010 03:00:00 PDT
The human papillomavirus increasingly is being identified as the cause of head and neck cancers, prompting some physicians to guess that the genesis of the cancers might be oral sex, the Raleigh News & Observer reports. David Brizel, an oncologist at Duke University who specializes in head and neck cancers, said, "A third of head and neck cancers we see nowadays are [related to] HPV...
Zetiq Reports CE Conformity For Its Cervical Cancer Diagnostic Kit published
Wed, 28 Jul 2010 01:00:00 PDT
Zetiq Technologies Ltd. ("Zetiq"), a subsidiary of Bio-Light Ltd. (TASE: BOLT), reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens...
Einstein Receives $4 Million To Test HPV Microbicide published
Sun, 25 Jul 2010 01:00:00 PDT
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from the seaweed derivative carrageenan in preventing new HPV infections in women...
)
|
|
